Mao Chung Chang
Direttore/Membro del Consiglio presso SYNEURX INTERNATIONAL (TAIWAN) CORP.
Profilo
Mao Chung Chang is currently a Director at SyneuRx International (Taiwan) Corp.
and a Professor at the University of California, Los Angeles.
Previously, he worked as a Director at Wintek Corp.
Dr. Chang received his graduate and doctorate degrees from National Chiao Tung University and his undergraduate degree from National Taiwan University.
Posizioni attive di Mao Chung Chang
Società | Posizione | Inizio |
---|---|---|
SYNEURX INTERNATIONAL (TAIWAN) CORP. | Direttore/Membro del Consiglio | 01/07/2020 |
University of California, Los Angeles | Corporate Officer/Principal | - |
Precedenti posizioni note di Mao Chung Chang
Società | Posizione | Fine |
---|---|---|
WINTEK CORPORATION | Direttore/Membro del Consiglio | - |
Formazione di Mao Chung Chang
National Chiao Tung University | Doctorate Degree |
National Taiwan University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Wintek Corp.
Wintek Corp. Computer PeripheralsElectronic Technology Wintek Corp. engages in the research, development, design, manufacture and sales of liquid crystal displays (LCD), liquid crystal modules (LCM) and touch panels. Its products include touch panels, light guides, thin film transistor LCD & LCM, lighting and organic light-emitting diode. It was founded on April 26, 1990 and is headquartered in Taichung, Taiwan. | Electronic Technology |
SyneuRx International (Taiwan) Corp.
SyneuRx International (Taiwan) Corp. BiotechnologyHealth Technology SyneuRx International (Taiwan) Corp. engages in the manufacture and sale of medicines. It offers different kinds of medicines, which are useful for brain disorders like schizophrenia have largely failed to materialize and mental illnesses like depression, obsessive compulsive disorder, attention deficit hyperactivity disorder, autism and dementia. The company was founded by Kuo Chuan Tsai on April 2, 2013 and is headquartered in New Taipei, Taiwan. | Health Technology |
- Borsa valori
- Insiders
- Mao Chung Chang